Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.227 USD
-3.81%
Market Closed
Updated:
May 21, 2024
Sonoma Pharmaceuticals Inc
Net Issuance of Common Stock
|
Sonoma Pharmaceuticals Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Net Issuance of Common Stock
$4.3m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-2%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Issuance of Common Stock
$2.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Issuance of Common Stock
-$4.9B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-100%
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Issuance of Common Stock
-$1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
34%
|
CAGR 10-Years
14%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Issuance of Common Stock
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Sonoma Pharmaceuticals Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
4.3m
USD
4.3m
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Net Issuance of Common Stock amounts to 4.3m USD.
What is Sonoma Pharmaceuticals Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-2%
-2%
The average annual Net Issuance of Common Stock growth rates for Sonoma Pharmaceuticals Inc have been 25% over the past three years , -16% over the past five years , and -2% over the past ten years .
You don't have any saved screeners yet
